Kobayashi Yukari, Kim Juyong B, Moneghetti Kegan J, Kobayashi Yuhei, Zhang Ran, Brenner Daniel A, O'Malley Ryan, Schnittger Ingela, Fischbein Michael, Miller D Craig, Yeung Alan C, Liang David, Haddad Francois, Fearon William F
Division of Cardiovascular Medicine, Stanford University School of Medicine, 300 Pasteur Drive Room H2103, Stanford, CA, 94305, USA.
Stanford Cardiovascular Institute, Stanford, CA, USA.
Int J Cardiovasc Imaging. 2017 Nov;33(11):1693-1701. doi: 10.1007/s10554-017-1155-6. Epub 2017 May 17.
Valvulo-arterial impedance (Zva) has been shown to predict worse outcome in medically managed aortic stenosis (AS) patients. We aimed to investigate the association between Zva and left ventricular (LV) adaptation and to explore the predictive value of Zva for cardiac functional recovery and outcome after transcatheter aortic valve replacement (TAVR). We prospectively enrolled 128 patients with AS who underwent TAVR. Zva was calculated as: (systolic blood pressure + mean transaortic gradient)/stroke volume index). Echocardiographic assessment occurred at baseline, 1-month and 1-year after TAVR. The primary endpoints were to investigate associations between Zva and global longitudinal strain (GLS) at baseline as well as GLS change after TAVR. The secondary was to compare all-cause mortality after TAVR between patients with pre-defined Zva (=5 mmHg m/ml), stroke volume index (=35 ml/m), and GLS (=-15%) cutoffs. The mean GLS was reduced (-13.0 ± 3.2%). The mean Zva was 5.2 ± 1.6 mmHgm/ml with 55% of values ≥5.0 mmHgm/ml, considered to be abnormally high. Higher Zva correlated with worse GLS (r = -0.33, p < 0.001). After TAVR, Zva decreased significantly (5.1 ± 1.6 vs. 4.5 ± 1.6 mmHg*m/ml, p = 0.001). A reduction of Zva at 1-month was associated with GLS improvement at 1-month (r = -0.31, p = 0.001) and at 1-year (r = -0.36 and p = 0.001). By Kaplan-Meier analysis, patients with higher Zva at baseline had higher mortality (Log-rank p = 0.046), while stroke volume index and GLS did not differentiate outcome (Log-rank p = 0.09 and 0.25, respectively). As a conclusion, Zva is correlated with GLS in AS as well as GLS improvement after TAVR. Furthermore, a high baseline Zva may have an additional impact to traditional parameters on predicting worse mortality after TAVR.
瓣膜 - 动脉阻抗(Zva)已被证明可预测药物治疗的主动脉瓣狭窄(AS)患者的不良预后。我们旨在研究Zva与左心室(LV)适应性之间的关联,并探讨Zva对经导管主动脉瓣置换术(TAVR)后心脏功能恢复和预后的预测价值。我们前瞻性纳入了128例接受TAVR的AS患者。Zva的计算方法为:(收缩压 + 平均跨主动脉压差)/ 每搏量指数)。在TAVR术后基线、1个月和1年进行超声心动图评估。主要终点是研究基线时Zva与整体纵向应变(GLS)之间以及TAVR术后GLS变化之间的关联。次要终点是比较预先定义的Zva(=5 mmHg·m/ml)、每搏量指数(=35 ml/m)和GLS(=-15%)临界值的患者TAVR术后的全因死亡率。平均GLS降低(-13.0±3.2%)。平均Zva为5.2±1.6 mmHg·m/ml,55%的值≥5.0 mmHg·m/ml,被认为异常高。较高的Zva与较差的GLS相关(r = -0.33,p < 0.001)。TAVR术后,Zva显著降低(5.1±1.6 vs. 4.5±1.6 mmHg·m/ml,p = 0.001)。1个月时Zva的降低与1个月时GLS的改善相关(r = -0.31,p = 0.001)以及与1年时GLS的改善相关(r = -0.36,p = 0.001)。通过Kaplan-Meier分析,基线时Zva较高的患者死亡率较高(对数秩检验p = 0.046),而每搏量指数和GLS不能区分预后(对数秩检验p分别为0.09和0.25)。结论是,Zva在AS中与GLS相关,并且在TAVR术后与GLS改善相关。此外,高基线Zva在预测TAVR术后较差死亡率方面可能对传统参数有额外影响。